top of page

WELCOME TO CATHAID®

Catheter securement, made simple.

Cathaid® NextGen is an engineered securement device for PICCs, midlines, and central venous catheters. Easier on you, easier on your patients.

Img 1_edited.jpg
Img 2.png
img 3.png

Securement is now the standard of care.

More than 300 million intravenous catheters are placed every year in the U.S. alone.¹ Up to one in four fails before therapy is complete, driven by dislodgement, infection, and skin injury.²

 

The 2024 INS Infusion Therapy Standards of Practice are explicit: "Using a manufactured catheter stabilization device is preferred." Sutures are called out for needlestick risk, biofilm growth, and increased bloodstream infection risk.³

 

Every prevented CLABSI saves an estimated $30,000 to $55,000.⁴ Securement is the cheapest place to start

300M+

intravenous catheters placed

1 in 4

fails before therapy finishes

$30-55K

per CLABSI

Using a manufactured catheter stabilization device is preferred.

Meet Cathaid® NextGen.

Cathaid® NextGen is a securement device (not a dressing) designed to replace tape, sutures, and legacy clip and anchor systems for PICCs, midlines, and central venous catheters.

Single lid: one closure, one motion. Flexible pins conform to the catheter hub on first close, with no manual repositioning.

And it holds: 15 lb of pull force in benchtop testing.⁵

One platform works across the hub geometries of the major catheter brands, in two adhesive options for different skin needs.

SINGLE LID   ·   FLEXIBLE PINS   ·   15 LB HOLD   ·   WORKS ACROSS MAJOR BRANDS

exploded view-1 (no blue container).png

Engineered as one system. Sterilized by e-beam. Built to be simple at the bedside.

Every layer has a job.

01

MOLDED CLIP:

A single-polymer clip carries the mechanical load: 15 lb of hold that never depends on adhesive gripping the line.⁵

02

SINGLE LID + FLEXIBLE PINS:

One closure, one motion. The pins conform to the catheter hub on first close, with no manual repositioning.

03

FOAM CUSHION:

A comfort layer between clip and skin pad that distributes clip load over the contact area.

04

SKIN-CONTACT PAD:

Your choice of substrate: hydrocolloid for fragile, MARSI-sensitive skin, or breathable polyester tricot with acrylic adhesive for everyday use.

05

LINERS:

Peel in sequence for a clean, repeatable application every time.

19366-[Converted].png

CHOOSE THE RIGHT SECUREMENT SOLUTION

One Device. Two Adhesive Options.

Cathaid® NextGen is available in two adhesive options to support different patient needs while providing secure hold for PICCs, midlines, and central venous catheters.

HYDROCOLLOID VERSION

Designed for patients with fragile or at-risk skin.

The Hydrocolloid version is designed for MARSI-sensitive patients, including oncology, neonatal, geriatric, and long dwell patients. The hydrocolloid adhesive conforms to the skin, absorbs moisture, and helps reduce mechanical and moisture associated injury. It is designed for atraumatic removal without aggressive acrylic pull on fragile skin while minimizing adhesive contact area and preserving secure hold.

IDEAL FOR:

Oncology patients

Geriatric patients

Neonatal patients

Long-dwell catheters

MARSI-sensitive skin

ACRYLIC VERSION

Designed for standard securement applications.

A breathable polyester tricot backing with a pressure sensitive acrylic adhesive: strong initial tack and reliable multi day hold for everyday use. Because NextGen's clip carries the mechanical load, the adhesive doesn't have to do the securement's job.

CONSIDERATIONS:

Strong initial adhesion

Suited when fragile skin is not the primary concern

Select by patient skin condition and clinical need

Request samples.

Evaluating securement for your unit? Tell us about your vascular access program and we'll send samples and pricing.

Call Today:

Email Us:

Location:

4487 Columbia Road Suite 201 Martinez, GA 30907

Thanks, we'll be in touch within one business day

One device. Every catheter. Secure.

© 2026 Cathaid® Inc. All rights reserved. Cathaid® is a registered trademark of Cathaid® Inc.

Quick Links

Cathaid® NextGen is a Class I, 510(k)-exempt medical device. Rx only.

Contact info

Call Today:

Email Us:

Location:

4487 Columbia Road Suite 201 Martinez, GA 30907

1. Comprehensive review of catheter dislodgement: prevalence, clinical impact, and innovations in securement devices. npj Biomedical Innovations, 2025. doi:10.1038/s44385-025-00049-3 (approx. 300 million intravenous catheter insertions annually in the U.S.).

2. Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of Central Venous Access Devices: A Systematic Review. Pediatrics. 2015;136(5) (25% of CVADs failed before completion of therapy); npj Biomedical Innovations 2025, op. cit. (PIVC dislodgement up to 24.5%).

3. Infusion Therapy Standards of Practice, 2024. Infusion Nurses Society. J Infus Nurs 47(1S), Standards 38-39 (Securement).

4. AHRQ and CDC-aligned cost analyses, 2017-2024. Published per-case attributable cost $30,000 to $55,000 depending on acuity and ICU status.

5. Internal benchtop pull testing, Cathaid® Inc. Methodology available on request.

bottom of page